When it comes to approving drugs, the FDA relies heavily on its advisory committees to help it make decisions. Most of the members of the committees are doctors and researchers who are supposed to be “independent” — meaning free from undue influence from pharmaceutical companies — so that their decisions are considered reasonably free from conflicts of interest.
Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.
Did you find this article helpful?